Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistGussyup LLC dba Private Label Grooming, a drug manufacturer in Henderson, Nevada, was cited for significant Current Good Manufacturing Practice (CGMP) violations in finished pharmaceuticals following an FDA inspection in February 2025. The company's quality control unit failed to ensure products met established specifications for identity, strength, quality, and purity, including inadequate testing of finished products prior to release, lack of an adequate stability program, and incomplete batch production and control records. The firm had already discontinued its OTC drug manufacturing operations and notified the FDA it did not intend to continue producing drug products, though no formal corrective action response to the inspection findings was received.